Approval · Notice of Compliance 5787 · 1994
ETOPOSIDE: Notice of Compliance 5787
Issued February 15, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5787
- Date
- February 15, 1994
- Company
- Abic LimitedNetanya, Israel
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antineoplastic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ETOPOSIDE | 02074796 | — |
Medicinal ingredients
- ETOPOSIDE 20 MG per ML